Thrombocytopenia in HIV-infected and uninfected hemophiliacs

American Journal of Hematology

Volumn 54, Issue 4, 1997, Pages 296-300

  Ehmann, W C ^a   Rabkin, C S ^b   Eyster, M E ^a   Goedert, J J ^b  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Hemophiliacs; HIV infection; Survival; Thrombocytopenia

Indexed keywords

ZIDOVUDINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CAUSE OF DEATH; COHORT ANALYSIS; CONTROLLED STUDY; HEMOPHILIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SURVIVAL; THROMBOCYTOPENIA;

ADOLESCENT; ADULT; CHILD; COHORT STUDIES; HEMOPHILIA A; HIV SEROPOSITIVITY; HUMANS; MIDDLE AGED; PREVALENCE; PROGNOSIS; THROMBOCYTOPENIA;

EID: 0030892518     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199704)54:4<296::AID-AJH6>3.0.CO;2-Q     Document Type: Article

References (13)

1. Rossi G, Gorla R, Stellini R, et al: Prevalence, clinical and laboratory features of thrombocytopenia among HIV-infected individuals. AIDS Res Hum Retroviruses 6:261-269, 1990.
2. Murphy MF, Metcalfe P, Waters AH, et al: Incidence and mechanism of neutropenia and thrombocytopenia in patients with human immunodeficiency virus infection. Br J Haematol 66:337-340, 1987.
3. Muñoz M, Carey V, Saah AJ, et al: Predictors of decline in CD4 lymphocytes in a cohort of homosexual men infected with human immunodeficiency virus. J Acquir Immune Defic Syndr 1:396-404, 1988.
4. Peltier JY, Lambin P, Doinel C, Couroucé AM, Rouger P, Lefrère JJ: Frequency and prognostic importance of thrombocytopenia in symptom-free HIV-infected individuals: A 5-year prospective study. AIDS 5:381-384, 1991.
5. Eyster ME, Gail MH, Ballard JO, Al-Mondhiry H, Goedert JJ: Natural history of human immunodeficiency virus infections in hemophiliacs: Effects of T-cell subsets, platelet counts and age. Ann Intern Med 107:1-6, 1987.
6. Schechter MT, Craib KJP, Le TN, et al: Progression to AIDS and predictors of AIDS in seroprevalent and seroincident cohorts of homosexual men. AIDS 3:347-353, 1989.
7. Moss AR, Bacchetti P, Osmond D, et al: Seropositivity for HIV and the development of AIDS or AIDS related conditions: Three year follow-up of the San Francisco General Hospital cohort. BMJ 296: 745-750, 1988.
8. Eyster ME, Rabkin CS, Hilgartner MW, et al: Human immunodeficiency virus-related conditions in children and adults with hemophilia: Rates, relationship to CD4 counts, and predictive value. Blood 81: 828-834, 1993.
9. The Swiss Group for Clinical Studies on the Acquired Immunodeficiency Syndrome (AIDS): Zidovudine for the treatment of thrombocytopenia associated with human immunodeficiency virus (HIV). Ann Intern Med 109:718-721, 1988.
10. Diamondstone LS, Blakley SA, Rice JC, Clark RA, Goedert JJ: Prognostic factors for all-cause mortality among hemophiliacs infected with human immunodeficiency virus. Am J Epidemiol 142:304-313, 1995.
11. Darby SC, Ewart DW, Giagrande PLF, Dolin PJ, Spooner RJD, Rizza Cr: Mortality before and after HIV infection in the complete UK population of hemophiliacs. Nature 377:79-82, 1995.
12. Ragni MV, Bontempo FA, Myers DJ, Kiss JE, Oral A: Hemorrhagic sequelae of immune thrombocytopenic purpura in human immunodeficiency virus-infected hemophiliacs. Blood 75:1267-1272, 1990.
13. Eyster ME, Diamondstone LS, Lien JM, Ehmann WC, Quan S, Goedert JJ, for the Multicenter Hemophilia Cohort Study: Natural history of hepatitis C virus infection in multitransfused hemophiliacs. Effect of confection with human immunodeficiency virus. J Acquir Immune Defic Syndr 6:602-610, 1993.